Browse > Article

Effects of Saengjihwangeum-ja Extracts on the Expression of Inflammatory Response in Human Monocyte Cells Induced by Advanced Glycation End Product  

Lee, Kwang-Gyu (Department of Pathology, College of Oriental Medicine, Woosuk University)
Han, Ung (Department of Pathology, College of Oriental Medicine, Woosuk University)
Jeong, Han-Sol (Department of Pathology, College of Oriental Medicine, Woosuk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.23, no.6, 2009 , pp. 1305-1313 More about this Journal
Abstract
Saengjihwangeum-ja (SJHEJ) was recorded in DongEuiBoGam as being able to be used for treatment of Sogal whose concept had been applied to Diabetes Mellitus (DM). Modification of proteins by long term circulation of glucose leads to the formation of advanced glycation end product(AGE). Recent immunological studies demonstrated that ligation of AGE play an important role in the development of diabetic complications including atherosclerosis, which includes activation, adhesion, and migration of monocytes. Also, AGE and Maillard reaction product(MRP) could augment monocyte inflammatory responses via ligation of AGE receptor. In this study, the effects of SJHEJ extracts on the expression of inflammatory response-related genes such as tumor necrosis factor-$\alpha$, monocyte chemoattractant protein-1, interferon-g-inducible protein-10, and cyclooxygenase-2 in the human monocyte cell line, THP-1 cells. Reverse transcriptase-polymerase chain reaction revealed that SJHEJ had inhibitory effects on the expression of the TNF-a, MCP-1, IP-10, COX2, IL-1b genes in MRP-induced THP-1 cells. Treatment with SJHEJ had reduced reactive oxygen production in THP-1 cells stimulated by MRP. These inhibitory effects might be exerted via prevention of oxidative stress in activated monocytes. In addition, radical scavenging activity of SJHEJ was increased. These results suggest that SJHEJ has a beneficial effects for improve diabetic vascular complication.
Keywords
AGE; maillard reaction product;
Citations & Related Records
연도 인용수 순위
  • Reference
1 이준영, 김대중, 김재용, 김화영, 민경완, 백세현 외. 당뇨병 기초통계연구 TFT 심포지움 : 2005-2006년 당뇨병 기초통계 연구 TFT 중간 보고 ; DisMod를 이용한 우리나라 당뇨병 유병률의 추정. 대한 당뇨병학회, pp 224-226, 2006
2 Bucala, R., Cerami, A., Vlassara, H. Advanced glycosylation end products in diabetic complications. Diabetes Rev 3: 258-268, 1995
3 葛芳芳., 李紅淺, 徐蓉娟. 淺析 '內經' 中消渴之論述, 上海中醫藥雜誌, 41: 60-62, 2007   PUBMED
4 黃瑛. 淺議《外科正宗》對消渴脫疽的論治. 新中醫 37: 77-78, 2005
5 曹孝忠 외. 聖濟總錄. 신문풍출판공사, pp 504-520, 1994
6 許 浚. 東醫寶鑑․雜病篇 卷六 消渴, 서울, 법인문화사, p 1405, 2007
7 Mishell, B.B. and Shiingi, S.M. Selected methods in cellular immunology. Freeman and W. M. Co., San Francisco, p 16, 1980
8 Mosmann, T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxic assays. J. Immunol. Methods 65: 55-63, 1983   DOI   PUBMED   ScienceOn
9 Birch, D.E., Kolmodin, L., Laird, W.J., McKinney, N., Wong, J., Young, K.K.Y., Zangenberg, G.A., Zoccoli, M.A. Simplified Hot-Start PCR. Nature 381: 445-446, 1996   DOI   PUBMED   ScienceOn
10 Schmidt, A., Hori, O., Brett, J., Yan, S.D., Wautier, J.L., Stern, D. Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521-1528, 1994   DOI   PUBMED
11 Horiuchi, S., Sano, H., Higashi, T., Ikeda, K., Jinnouchi, Y., Nagai, R., et al. Extra- and intracellular localization of advanced glycation end-products in human atherosclerotic lesions, Nephrol Dial Transplant 11(5):81-86, 1996
12 H. Vlassara, R. Bucala, L. Striker. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging, Lab Invest 70: 138-151, 1994   PUBMED
13 金達鎬. 注解補注 黃帝內經 靈樞, 서울, 醫聖堂, p 877, 2002
14 Gu, L., Tseng, S.C., Rollins, B.J. Monocyte chemoattractant protein-1. Chem Immunol 72: 7-29, 1999   DOI   PUBMED
15 Shimada, A., Morimoto, S.A., Kodama, K., Suzuki, R., Oikawa, Y., Saruta, T., et al. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24: 510-515, 2001   DOI   ScienceOn
16 Miquel, J., Quintanilha, A.T., Weber, H. Handbook of free radicals and antioxidants in biomedicine. CRC Press, 1: 223, 1989
17 Bierhaus, A., Hofmann, M.A., Ziegler, R., Nawroth, P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37: 586-600, 1998   DOI   ScienceOn
18 許浚. 東醫寶鑑 雜病篇 卷六 消渴. 서울, 법인문화사, p 1408, 2007
19 M. Brownlee, Advanced protein glycosylation in diabetes and aging, Ann Rev Med 46: 223-234, 1995   DOI   ScienceOn
20 Rahbar, S., Blumenfeld, O., Ranney, H.M. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochemical and Biophysical Research Communications 36: 838-843, 1969   DOI   ScienceOn
21 S.K. Grandhee and V.M. Monnier. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors, J Biol Chem 266: 11649-11653, 1991   PUBMED
22 危亦林. 世醫得效方. 서울, 도서출판 금강출판사, pp 167-168, 1981
23 Inoue, H., Umesono, K., Nishimori, T., Hirata, T., Tanabe, T. Glucocorticoid-mediated suppression of the promotor activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Bioph Res Commun 254: 292-298, 1999   DOI   ScienceOn
24 Bucala, R., Cerami, A., Vlassara, H. Advanced glycosylation end products in diabetic complications. Diabetes Rev 3: 258-268, 1995
25 Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001   DOI   PUBMED   ScienceOn
26 Chappy, O., Dosquet, C., Wautier, M.P., Wautier, J.L. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27: 97-108, 1997   DOI   ScienceOn
27 Sheetz, M.J., King, G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588, 2002   DOI   ScienceOn
28 Ahemed, N., Thornalley, P.J. Advanced glycation endproduct: what is their relevance to diabetic complications?. Diabetes, Obesity and Metabolism 9: 233-245, 2007   DOI   ScienceOn
29 楊士瀛. 仁齊直指, 卷十七, 消渴, 消渴方論. 서울, 여강출판사, (12) p (744)329, 1995
30 劉河間. 傷寒 三六書. 서울, 성보사, pp 82-83, 1976
31 Pugliese, G., Tilton, R.G., Williamson, J.R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabete Metab Rev 7: 35-59, 1991   DOI   ScienceOn
32 王燾. 外臺秘要, 卷十一, 消渴方一十七首, 서울, 대성문화사, p 339, 1992
33 Tabatabaie, T., Vasquez-Weldon, A., Moore, D.R., Kotake, Y. Free Radicals and the Pathogenesis of Type 1 Diabetes: beta-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2. Diabetes 52: 1994-1999, 2003   DOI   ScienceOn
34 楊思樹, 張樹生, 傳景華 主編, 안세영 역. 동의임상내과학. 서울 법인문화사, pp 396-413, 1999
35 Blois, M.S. Antioxidant determination by the use a stable free radicals. Nature. 26: 1191-1204, 1958
36 Rahbar, S. Hemoglobin H disease in two Iranian families, Clinica Chimica Acta 20: 381-385, 1968   DOI   ScienceOn
37 金達鎬. 注解補注 黃帝內經 素問(上) 서울, 도서출판 의성당, p 974, 2001
38 巢元方. 巢氏諸病源候論, 卷五, 消渴病諸候 消渴候, 臺中, 昭人出版社, p 161
39 孫思邈. 備急千金要方, 서울, 대성문화사, p 651, 1992
40 李杲. 東垣十種醫書, 서울, 대성문화사, pp 164-167, 1983
41 Diabetes Atlas: International Diabetes Federation, 2nd ed., Brussels, 2003
42 金禮蒙. 醫方類聚, 六券 , 서울, 醫聖堂, p 344, 1993
43 American Diabetes Association. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care. 12: 573-579, 1989   DOI   PUBMED
44 Geiss, L., Herman, W., Smith, P. Mortality in non-insulin dependent diabetes. National Institutes of Health, Bethesda, pp 233-258, 1995
45 杜鎬京. 東醫腎系學, 서울, 동양의학연구원, pp 939-990, 1991
46 龔廷賢. 萬病回春. 臺北, 大中國圖書公私, pp 70-71, 1983
47 Ruderman, N., Williamson, J.R., Brownlee, M. Glucose and diabetic vascular disease. FASEB J 6: 2905-2914, 1992   DOI   PUBMED
48 대한병리학회. 병리학II. 제6판. Korea Seoul Komoonsa Medical Science, p 702, 2007
49 Shanmugam, N., Reddy, M.A., Guha, M., Natarajan, R. High glucose-induced expressioin of proinflammatory cytokine and chemokine gene in monycytic cells. Diagetes 52: 1256-1264, 2003   DOI   ScienceOn
50 강석봉. 소갈의 전병증과 당뇨병의 만성합병증에 대한 비교 고찰, 대한한의학회지 36: 137-152, 1998
51 葛芳芳, 李紅淺, 徐蓉娟. 淺析 '內經' 中消渴之論述, 上海中醫藥雜誌 41: 60-62, 2007   PUBMED
52 Brownlee, M., Cerami, A., Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988   DOI   PUBMED   ScienceOn